Icon

ANORO ELLIPTA (nda203975)- (EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH)

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE GLAXOSMITHKLINE
EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH
No No
2031-Apr-11 2018-Dec-18
None 2016-Dec-18
None No
ANORO ELLIPTA is a combination of umeclidinium, an anticholinergic, and vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers 3
Drugs with Suitability No
EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.